Authors


Tiffany Iwamura, PharmD

Latest:

Evaluating Satisfaction With Pharmacist-Provided MTM Services in a Medicaid Population

Medication therapy management (MTM) services were performed with a cohort of Medicaid patients, and their satisfaction with the program was assessed as part of a quality improvement initiative.



Mark Sevco, MBA, MHA

Latest:

Consumer-Centric Approach to Enhance Access to Pediatric Specialty Care

The authors’ organization optimized scheduling techniques that improved patient access to pediatric specialists to within 7 calendar days for new patients.


Ellis C. Dillon, PhD

Latest:

Primary Care Nurse Practitioner Management of Adolescent Behavioral Health

Personnel costs ($90,514) of a primary care–embedded adolescent behavioral health nurse practitioner over 2 years were 63% of the potential revenue generated ($144,449).


Catherine Loden, BS

Latest:

Estimating the Economic Burden of Migraine on US Employers

The Migraine Impact Model is an interactive calculator that estimates migraine prevalence within a workforce and the associated economic burden of migraine on the employer.


Jennifer Perloff, PhD

Latest:

Characteristics of Home-Based Care Provided by Accountable Care Organizations

Accountable care organizations (ACOs) deliver a diverse array of home-based services, but many of the services are not reimbursed. ACOs may not expand these programs without strong evidence of cost savings.


Sonal Parasrampuria, PhD, MPH

Latest:

Effects of an Out-of-Pocket Maximum in Medicare Part D

This study compares the impact of the 3 different out-of-pocket maximums proposed in Congress and by the Medicare Payment Advisory Commission.


Kelly Procailo, PharmD, BCOP

Latest:

The Impact of Immune Checkpoint Inhibitors on Cost and Quality of Life in the Initial Treatment of Patients With Advanced or Metastatic NSCLC

Immune checkpoint inhibitors (ICIs) represent a significant benefit for the initial treatment of patients with advanced or metastatic non−small cell lung cancer (NSCLC). Beyond clinical benefit of increased overall survival, it represents a class of medications with a favorable adverse effect profile compared with chemotherapy. Drugs that target programmed cell death protein 1 (PD-1) receptor and its ligand PD-L1 are ICIs that work by taking the brakes off the immune system and promote T-cell−mediated cancer cell destruction. Current NCCN guidelines recommend that all patients with advanced or metastatic NSCLC have their PD-L1 status (amount of PD-L1 on cancer cells) assessed to guide treatment section. However, this recommendation is not always followed and may lead to inappropriate treatment selection and potential increased cost. Through appropriate biomarker testing, subsequent appropriate utilization of ICIs may help to drive down other costs and improve health-related quality of life. Managed care pharmacists should continue to focus on promotion of guideline concordant care that includes appropriate biomarker testing and selection of an evidence-based preferred treatment option.


Ru Peng Mong, MBBS

Latest:

Evaluating Smoking Cessation Service at an Emergency Department Clinical Observation Unit

This study aimed to evaluate the impact of a smoking cessation service in a group of patients admitted to a short-stay unit in the emergency department.


Morgane C. Mouslim, DVM, ScM

Latest:

The Price Paradox of Biosimilar-Like Long-Acting Insulin

Findings suggest that Basaglar was not less expensive for patients than Lantus. Empirical evaluation of biosimilar costs prior to automatic substitution is necessary.


Martin Rosenzweig, MD

Latest:

Optimizing the Management of TRD

Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.


K. Dennie Kim, PhD

Latest:

Care Fragmentation Predicts 90-Day Durable Ventricular Assist Device Outcomes

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.


Hsiu-Wen Kuo, MSN

Latest:

Impact of COVID-19 Pandemic on Accessibility of Taiwanese Medical Care

The COVID-19 pandemic disrupted access to routine medical care in community populations in Taiwan. The unmet needs should be emphasized as normal life resumes.


Mindy M. Cheng, PhD, MS

Latest:

US Cost-effectiveness and Budget Impact of Point-of-Care NAAT for Streptococcus

This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus.


Lauren Massaro

Latest:

Researchers Propose Model to Replicate Patient Experience in Artificial Pancreas System

A methodology to monitor patient-in-the-loop modes and faults was examined using a hybrid automata model that was able to replicate patient’s real-life operation modes.


Aimee M. Near, MPH

Latest:

Real-world HIV Diagnostic Testing Patterns in the United States

This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory.


Matthew R. Augustine, MD, MS

Latest:

Growth of Electronic Consultations in the Veterans Health Administration

This study evaluates the growth in electronic consultation use over the first 7 years after its implementation across the entire Veterans Health Administration system.


Miku Sodhi, MBBS, MHA

Latest:

Ensuring Access to Health Care by FQHCs as States Reopen Amid COVID-19

Federally qualified health centers (FQHCs) must focus on enhancing the nonemergency medical transportation Medicaid benefit to improve patient access during the coronavirus disease 2019 (COVID-19) emergency as states reopen.


Milena Sullivan, MA

Latest:

Considerations to Increase Rates of Breast Cancer Screening Across Populations

Authors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.


Dhaval Patil, MS, BPharm

Latest:

Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review

This review describes the impact of nonmedical switching of biologic therapies on US patients and providers, with a focus on switching to in-class alternatives.


Ann-Kathrin Klaehn, MSc

Latest:

Cost-effectiveness of Case Management: A Systematic Review

This systematic review found that studies of case management interventions have adequate quality and, in many cases, show cost-effective or even cost-saving results.


Amelia M. Bond, PhD

Latest:

Physician Prices and Low-Value Services: Evidence From General Internal Medicine

This study found extensive variation in general internal medicine physician prices and that high-priced physicians provided fewer low-value services but had higher spending on these services.


Allison J. Zomer, MDP

Latest:

Using a Brief Tool to Assess Healthy School Environments: A Pilot Study

The authors evaluated a brief assessment tool that accountable care organizations can use to help elementary schools improve student nutrition and increase physical activity.


Ashwini Sankar, PhD

Latest:

FDA Safety Warnings and Trends in Testosterone Marketing to Physicians

This article presents an evaluation of testosterone marketing practices around the period of the testosterone label warning by physician specialty and rural vs urban primary care service area.


Loren Adler, MS

Latest:

Commercial and Medicare Advantage Payment for Anesthesiology Services

Mean in-network commercial allowed amounts and charges per anesthesia conversion factor are 314% and 659% of traditional Medicare rates, respectively. Medicare Advantage payments align with traditional Medicare prices.


Sachin Kamal-Bahl, PhD

Latest:

Financial Incentives Tied to Medicare Star Ratings: Impact on Influenza Vaccination Uptake in Medicare Beneficiaries

Influenza vaccine uptake improved among Medicare Advantage enrollees when influenza vaccination was introduced as a performance metric in Medicare star ratings and accompanying bonus payments.


Thomas Kannampallil, PhD

Latest:

Classifying Clinical Work Settings Using EHR Audit Logs: A Machine Learning Approach

An automated pipeline of frequency representation and machine learning models on raw electronic health record (EHR) audit logs can classify work settings based on clinical work activities.


Nate C. Apathy, PhD

Latest:

Growth in Health Information Exchange With ACO Market Penetration

Hospitals that participate in accountable care organizations (ACOs) expand their health information exchange networks as a result, but hospitals in markets with existing ACO infrastructure can expand more quickly.


Mamta Bhatia, MSGH

Latest:

Patient Experience After Modifying Visit Delivery During the COVID-19 Pandemic

Coronavirus disease 2019 (COVID-19) was associated with immediate weekly visit trend decreases for overall, primary care, and specialty care with long-term recovery trends; transformation to virtual visits; and increasing long-term trends for meeting patient scheduling and visit needs.


Kelly E. Anderson, MPP

Latest:

Regulation of Provider Networks in Response to COVID-19

The authors describe federal and state provider network adequacy standards and discuss how regulators should adapt these standards and accompanying monitoring processes in response to coronavirus disease 2019 (COVID-19).

© 2023 MJH Life Sciences
AJMC®
All rights reserved.